Johns Hopkins Diabetes GuideBrand Names

Bromocriptine

Aniket Sidhaye, M.D., Paul Pham, Pharm.D. BCPS
Bromocriptine is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

  • Bromoctriptine-quick release (QR) approved in 2009 for type 2 diabetes mellitus, as an adjunct to diet and exercise
  • Previous indications include: prolactin-secreting adenomas, hyperprolactinemia, acromegaly, Parkinson’s disease

NON-FDA APPROVED USES

  • Neuroleptic malignant syndrome

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: April 9, 2015